These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 11009747)

  • 61. The impact of the introduction of market incentives on occupational health services and occupational health professionals: experiences from The Netherlands.
    Plomp HN
    Health Policy; 2008 Oct; 88(1):25-37. PubMed ID: 18387690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Health sector reforms in Argentina and the performance of the health financing system.
    Cavagnero E
    Health Policy; 2008 Oct; 88(1):88-99. PubMed ID: 18378350
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Requirements for the group health insurance market; non-federal governmental plans exempt from HIPAA Title I requirements. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2004 Jul; 69(141):43926-8. PubMed ID: 15272481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gender equity and health sector reform in Colombia: mixed state-market model yields mixed results.
    Ewig C; Bello AH
    Soc Sci Med; 2009 Mar; 68(6):1145-52. PubMed ID: 19167142
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preferences and choices for care and health insurance.
    van den Berg B; Van Dommelen P; Stam P; Laske-Aldershof T; Buchmueller T; Schut FT
    Soc Sci Med; 2008 Jun; 66(12):2448-59. PubMed ID: 18400349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk-adjusted capitation payment systems for health insurance plans in a competitive market.
    Lamers LM; van Vliet RC; van de Ven WP
    Expert Rev Pharmacoecon Outcomes Res; 2003 Oct; 3(5):541-9. PubMed ID: 19807388
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Statutory health insurance competition in Europe: a four-country comparison.
    Thomson S; Busse R; Crivelli L; van de Ven W; Van de Voorde C
    Health Policy; 2013 Mar; 109(3):209-25. PubMed ID: 23395277
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Why not private health insurance? 2. Actuarial principles meet provider dreams.
    Deber R; Gildiner A; Baranek P
    CMAJ; 1999 Sep; 161(5):545-7. PubMed ID: 10497614
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The cost conundrum: financing the business of health care insurance.
    Kelly A
    J Health Care Finance; 2013; 39(4):15-27. PubMed ID: 24003758
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of purchaser competition in the Dutch health system: is the glass half full or half empty?
    Schut FT; van de Ven WP
    Health Econ Policy Law; 2011 Jan; 6(1):109-23. PubMed ID: 21269527
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is the medical loss ratio a good target measure for regulation in the individual market for health insurance?
    Karaca-Mandic P; Abraham JM; Simon K
    Health Econ; 2015 Jan; 24(1):55-74. PubMed ID: 24123608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of independent agents in the success of health insurance market reforms.
    Hall MA
    Milbank Q; 2000; 78(1):23-45, i-ii. PubMed ID: 10834080
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Perspectives. Individual market: endangered habitat for indemnity insurance.
    Cunningham R
    Faulkner Grays Med Health; 1996 Feb; 50(7):suppl 1-4. PubMed ID: 10154481
    [No Abstract]   [Full Text] [Related]  

  • 75. Adverse selection at academic health centers.
    Retchin SM
    Clin Perform Qual Health Care; 1998; 6(1):38-43. PubMed ID: 10177048
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Australia's private health insurance industry: structure, competition, regulation and role in a less than 'ideal world'.
    Shamsullah A
    Aust Health Rev; 2011 Feb; 35(1):23-31. PubMed ID: 21367326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Wall Street comes to Washington: analysts' perspectives on the changing health care system.
    Issue Brief Cent Stud Health Syst Change; 1999 Sep; (21):1-4. PubMed ID: 10915425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New Jersey insurers eye new market reforms.
    McGuire D; Jee M
    J Am Health Policy; 1993; 3(5):57-8. PubMed ID: 10128279
    [No Abstract]   [Full Text] [Related]  

  • 79. Research on competition in the market for health services: problems and prospects.
    Pauly MV; Langwell KM
    Inquiry; 1983; 20(2):142-61. PubMed ID: 6222985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aggressive regulator or passive price-taker: what role should HIPCs (health insurance purchasing cooperatives) play?
    Wicks EK
    J Am Health Policy; 1993; 3(4):21-5. PubMed ID: 10127493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.